Mercator Net Income From Continuing Ops from 2010 to 2026
| MM2 Stock | EUR 9.09 0.30 3.19% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -20.6 M | Current Value -19.5 M | Quarterly Volatility 237.9 M |
Check Mercator Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mercator Medical's main balance sheet or income statement drivers, such as Tax Provision of 14.9 M, Net Interest Income of 14 M or Interest Income of 13.6 M, as well as many indicators such as . Mercator financial statements analysis is a perfect complement when working with Mercator Medical Valuation or Volatility modules.
Mercator | Net Income From Continuing Ops |
The Net Income From Continuing Ops trend for Mercator Medical SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Mercator Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Mercator Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Mercator Medical SA over the last few years. It is Mercator Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mercator Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Mercator Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 297,746,401 | |
| Coefficient Of Variation | 79.91 | |
| Mean Deviation | 207,678,492 | |
| Median | 444,852,000 | |
| Standard Deviation | 237,942,466 | |
| Sample Variance | 56616.6T | |
| Range | 635.6M | |
| R-Value | (0.76) | |
| Mean Square Error | 25274.3T | |
| R-Squared | 0.58 | |
| Significance | 0.0004 | |
| Slope | (35,931,287) | |
| Total Sum of Squares | 905865.9T |
Mercator Net Income From Continuing Ops History
About Mercator Medical Financial Statements
Mercator Medical stakeholders use historical fundamental indicators, such as Mercator Medical's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Mercator Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mercator Medical's assets and liabilities are reflected in the revenues and expenses on Mercator Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mercator Medical SA. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -20.6 M | -19.5 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Mercator Stock
Mercator Medical financial ratios help investors to determine whether Mercator Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mercator with respect to the benefits of owning Mercator Medical security.